EP Wealth Advisors LLC Invests $479,000 in ICU Medical, Inc. $ICUI

Key Points

• EP Wealth Advisors LLC has acquired a new position in ICU Medical, purchasing 3,446 shares valued at approximately $479,000 in the first quarter.
• Several institutional investors significantly increased their stakes in ICU Medical, with The Manufacturers Life Insurance Company raising its holdings by 992.1%, now owning over 130,000 shares valued at $18.16 million.
• ICU Medical reported $2.10 earnings per share for the latest quarter, surpassing expectations, but noted an 8.0% decline in revenue compared to the same quarter last year.

EP Wealth Advisors LLC purchased a new stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 3,446 shares of the medical instruments supplier's stock, valued at approximately $479,000.

Other hedge funds also recently modified their holdings of the company. GAMMA Investing LLC increased its position in shares of ICU Medical by 27.2% during the 1st quarter. GAMMA Investing LLC now owns 716 shares of the medical instruments supplier's stock valued at $99,000 after purchasing an additional 153 shares during the period. Blue Trust Inc. increased its position in shares of ICU Medical by 23.0% during the 1st quarter. Blue Trust Inc. now owns 801 shares of the medical instruments supplier's stock valued at $111,000 after purchasing an additional 150 shares during the period. Vontobel Holding Ltd. acquired a new position in shares of ICU Medical during the 1st quarter valued at $235,000. Xponance Inc. increased its position in shares of ICU Medical by 5.3% during the 1st quarter. Xponance Inc. now owns 1,714 shares of the medical instruments supplier's stock valued at $238,000 after purchasing an additional 86 shares during the period. Finally, Vident Advisory LLC acquired a new position in shares of ICU Medical during the 1st quarter valued at $270,000. 96.10% of the stock is currently owned by institutional investors and hedge funds.

ICU Medical Stock Up 0.3%

Shares of ICUI stock traded up $0.39 on Thursday, reaching $133.96. 194,222 shares of the company's stock traded hands, compared to its average volume of 267,182. ICU Medical, Inc. has a 12-month low of $107.00 and a 12-month high of $196.26. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.17 and a current ratio of 2.44. The company has a market capitalization of $3.31 billion, a P/E ratio of -88.13 and a beta of 0.86. The business's 50 day moving average price is $126.34 and its two-hundred day moving average price is $134.19.

ICU Medical (NASDAQ:ICUI - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $2.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.44 by $0.66. The firm had revenue of $543.57 million during the quarter, compared to analysts' expectations of $543.33 million. ICU Medical had a positive return on equity of 7.24% and a negative net margin of 1.56%.The business's revenue for the quarter was down 8.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.56 earnings per share. ICU Medical has set its FY 2025 guidance at 6.850-7.15 EPS. On average, equities analysts forecast that ICU Medical, Inc. will post 4.11 earnings per share for the current year.

Wall Street Analysts Forecast Growth

ICUI has been the topic of a number of recent research reports. Raymond James Financial decreased their target price on ICU Medical from $187.00 to $180.00 and set a "strong-buy" rating on the stock in a report on Friday, August 8th. Piper Sandler lifted their target price on ICU Medical from $145.00 to $153.00 and gave the stock an "overweight" rating in a report on Wednesday. Finally, Wall Street Zen upgraded ICU Medical from a "hold" rating to a "buy" rating in a report on Friday, September 5th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has given a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus price target of $181.00.

Insider Transactions at ICU Medical

In other ICU Medical news, CEO Vivek Jain acquired 21,929 shares of the company's stock in a transaction dated Thursday, August 14th. The shares were acquired at an average cost of $112.84 per share, for a total transaction of $2,474,468.36. Following the completion of the purchase, the chief executive officer owned 130,149 shares of the company's stock, valued at approximately $14,686,013.16. This trade represents a 20.26% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director David C. Greenberg acquired 1,200 shares of the company's stock in a transaction dated Wednesday, August 27th. The stock was acquired at an average price of $126.42 per share, for a total transaction of $151,704.00. Following the completion of the purchase, the director directly owned 7,960 shares of the company's stock, valued at $1,006,303.20. This trade represents a 17.75% increase in their position. The disclosure for this purchase can be found here. 1.50% of the stock is owned by insiders.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.